Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Clinical trial NCT06513962 · RECRUITING

Trial details

NCT number: NCT06513962
Sponsor: Children's Oncology Group
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

Start date: 2025-02-27
Primary completion: 2029-10-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.